List of Tables
Table 1. In Vivo and In Vitro ADME and PK Market Trends
Table 2. In Vivo and In Vitro ADME and PK Market Drivers & Opportunity
Table 3. In Vivo and In Vitro ADME and PK Market Challenges
Table 4. In Vivo and In Vitro ADME and PK Market Restraints
Table 5. Global In Vivo and In Vitro ADME and PK Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global In Vivo and In Vitro ADME and PK Revenue Market Share by Company (2019-2024)
Table 7. Key Companies In Vivo and In Vitro ADME and PK Manufacturing Base Distribution and Headquarters
Table 8. Key Companies In Vivo and In Vitro ADME and PK Product Type
Table 9. Key Companies Time to Begin Mass Production of In Vivo and In Vitro ADME and PK
Table 10. Global In Vivo and In Vitro ADME and PK Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo and In Vitro ADME and PK as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global In Vivo and In Vitro ADME and PK Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global In Vivo and In Vitro ADME and PK Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global In Vivo and In Vitro ADME and PK Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global In Vivo and In Vitro ADME and PK Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global In Vivo and In Vitro ADME and PK Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global In Vivo and In Vitro ADME and PK Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global In Vivo and In Vitro ADME and PK Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global In Vivo and In Vitro ADME and PK Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global In Vivo and In Vitro ADME and PK Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global In Vivo and In Vitro ADME and PK Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global In Vivo and In Vitro ADME and PK Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global In Vivo and In Vitro ADME and PK Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global In Vivo and In Vitro ADME and PK Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global In Vivo and In Vitro ADME and PK Sales Value by Region (2019-2024) & (%)
Table 27. Global In Vivo and In Vitro ADME and PK Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions In Vivo and In Vitro ADME and PK Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions In Vivo and In Vitro ADME and PK Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions In Vivo and In Vitro ADME and PK Sales Value, (2025-2030) & (US$ Million)
Table 31. Charles River Basic Information List
Table 32. Charles River Description and Business Overview
Table 33. Charles River In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 34. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Charles River (2019-2024)
Table 35. Charles River Recent Developments
Table 36. Labcorp Basic Information List
Table 37. Labcorp Description and Business Overview
Table 38. Labcorp In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 39. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Labcorp (2019-2024)
Table 40. Labcorp Recent Developments
Table 41. ICON Basic Information List
Table 42. ICON Description and Business Overview
Table 43. ICON In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 44. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of ICON (2019-2024)
Table 45. ICON Recent Developments
Table 46. Syneos Health Basic Information List
Table 47. Syneos Health Description and Business Overview
Table 48. Syneos Health In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 49. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Syneos Health (2019-2024)
Table 50. Syneos Health Recent Developments
Table 51. Envigo Basic Information List
Table 52. Envigo Description and Business Overview
Table 53. Envigo In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 54. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Envigo (2019-2024)
Table 55. Envigo Recent Developments
Table 56. Curia Basic Information List
Table 57. Curia Description and Business Overview
Table 58. Curia In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 59. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Curia (2019-2024)
Table 60. Curia Recent Developments
Table 61. Evotec Basic Information List
Table 62. Evotec Description and Business Overview
Table 63. Evotec In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 64. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Evotec (2019-2024)
Table 65. Evotec Recent Developments
Table 66. Bioduro-Sundia Basic Information List
Table 67. Bioduro-Sundia Description and Business Overview
Table 68. Bioduro-Sundia In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 69. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Bioduro-Sundia (2019-2024)
Table 70. Bioduro-Sundia Recent Developments
Table 71. Lonza Basic Information List
Table 72. Lonza Description and Business Overview
Table 73. Lonza In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 74. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Lonza (2019-2024)
Table 75. Lonza Recent Developments
Table 76. WuXi AppTec Basic Information List
Table 77. WuXi AppTec Description and Business Overview
Table 78. WuXi AppTec In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 79. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of WuXi AppTec (2019-2024)
Table 80. WuXi AppTec Recent Developments
Table 81. IQVIA Basic Information List
Table 82. IQVIA Description and Business Overview
Table 83. IQVIA In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 84. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of IQVIA (2019-2024)
Table 85. IQVIA Recent Developments
Table 86. Tecan Group Basic Information List
Table 87. Tecan Group Description and Business Overview
Table 88. Tecan Group In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 89. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Tecan Group (2019-2024)
Table 90. Tecan Group Recent Developments
Table 91. Pharmaron Basic Information List
Table 92. Pharmaron Description and Business Overview
Table 93. Pharmaron In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 94. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Pharmaron (2019-2024)
Table 95. Pharmaron Recent Developments
Table 96. Shanghai Medicilon Basic Information List
Table 97. Shanghai Medicilon Description and Business Overview
Table 98. Shanghai Medicilon In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 99. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Shanghai Medicilon (2019-2024)
Table 100. Shanghai Medicilon Recent Developments
Table 101. ChemPartner Basic Information List
Table 102. ChemPartner Description and Business Overview
Table 103. ChemPartner In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 104. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of ChemPartner (2019-2024)
Table 105. ChemPartner Recent Developments
Table 106. Joinn Laboratories Basic Information List
Table 107. Joinn Laboratories Description and Business Overview
Table 108. Joinn Laboratories In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 109. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Joinn Laboratories (2019-2024)
Table 110. Joinn Laboratories Recent Developments
Table 111. RTI International Basic Information List
Table 112. RTI International Description and Business Overview
Table 113. RTI International In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 114. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of RTI International (2019-2024)
Table 115. RTI International Recent Developments
Table 116. Eurofins Scientific Basic Information List
Table 117. Eurofins Scientific Description and Business Overview
Table 118. Eurofins Scientific In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 119. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Eurofins Scientific (2019-2024)
Table 120. Eurofins Scientific Recent Developments
Table 121. Aragen Life Sciences Basic Information List
Table 122. Aragen Life Sciences Description and Business Overview
Table 123. Aragen Life Sciences In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 124. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Aragen Life Sciences (2019-2024)
Table 125. Aragen Life Sciences Recent Developments
Table 126. Sai Life Sciences Basic Information List
Table 127. Sai Life Sciences Description and Business Overview
Table 128. Sai Life Sciences In Vivo and In Vitro ADME and PK Products, Services and Solutions
Table 129. Revenue (US$ Million) in In Vivo and In Vitro ADME and PK Business of Sai Life Sciences (2019-2024)
Table 130. Sai Life Sciences Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. In Vivo and In Vitro ADME and PK Downstream Customers
Table 134. In Vivo and In Vitro ADME and PK Distributors List
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. In Vivo and In Vitro ADME and PK Product Picture
Figure 2. Global In Vivo and In Vitro ADME and PK Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global In Vivo and In Vitro ADME and PK Sales Value (2019-2030) & (US$ Million)
Figure 4. In Vivo and In Vitro ADME and PK Report Years Considered
Figure 5. Global In Vivo and In Vitro ADME and PK Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by In Vivo and In Vitro ADME and PK Revenue in 2023
Figure 7. In Vivo and In Vitro ADME and PK Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Small Molecules Picture
Figure 9. Biologics Picture
Figure 10. Global In Vivo and In Vitro ADME and PK Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global In Vivo and In Vitro ADME and PK Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Biopharmaceutical Companies
Figure 13. Product Picture of Government and Academic Institutes
Figure 14. Product Picture of Others
Figure 15. Global In Vivo and In Vitro ADME and PK Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global In Vivo and In Vitro ADME and PK Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America In Vivo and In Vitro ADME and PK Sales Value (2019-2030) & (US$ Million)
Figure 18. North America In Vivo and In Vitro ADME and PK Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe In Vivo and In Vitro ADME and PK Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe In Vivo and In Vitro ADME and PK Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific In Vivo and In Vitro ADME and PK Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific In Vivo and In Vitro ADME and PK Sales Value by Country (%), 2023 VS 2030
Figure 23. South America In Vivo and In Vitro ADME and PK Sales Value (2019-2030) & (US$ Million)
Figure 24. South America In Vivo and In Vitro ADME and PK Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa In Vivo and In Vitro ADME and PK Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa In Vivo and In Vitro ADME and PK Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions In Vivo and In Vitro ADME and PK Sales Value (%), (2019-2030)
Figure 28. United States In Vivo and In Vitro ADME and PK Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States In Vivo and In Vitro ADME and PK Sales Value by Type (%), 2023 VS 2030
Figure 30. United States In Vivo and In Vitro ADME and PK Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe In Vivo and In Vitro ADME and PK Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe In Vivo and In Vitro ADME and PK Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe In Vivo and In Vitro ADME and PK Sales Value by Application (%), 2023 VS 2030
Figure 34. China In Vivo and In Vitro ADME and PK Sales Value, (2019-2030) & (US$ Million)
Figure 35. China In Vivo and In Vitro ADME and PK Sales Value by Type (%), 2023 VS 2030
Figure 36. China In Vivo and In Vitro ADME and PK Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan In Vivo and In Vitro ADME and PK Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan In Vivo and In Vitro ADME and PK Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan In Vivo and In Vitro ADME and PK Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea In Vivo and In Vitro ADME and PK Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea In Vivo and In Vitro ADME and PK Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea In Vivo and In Vitro ADME and PK Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia In Vivo and In Vitro ADME and PK Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia In Vivo and In Vitro ADME and PK Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia In Vivo and In Vitro ADME and PK Sales Value by Application (%), 2023 VS 2030
Figure 46. India In Vivo and In Vitro ADME and PK Sales Value, (2019-2030) & (US$ Million)
Figure 47. India In Vivo and In Vitro ADME and PK Sales Value by Type (%), 2023 VS 2030
Figure 48. India In Vivo and In Vitro ADME and PK Sales Value by Application (%), 2023 VS 2030
Figure 49. In Vivo and In Vitro ADME and PK Industrial Chain
Figure 50. In Vivo and In Vitro ADME and PK Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
